1 completed, 1 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Terminated 1 |
Follow Prurigo Nodularis: new trials by email Literature Review of Prurigo Nodularis trials Research Report on Prurigo Nodularis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Upadacitinib for Prurigo Nodularis Upadacitinib - Prurigo Nodularis | Phase 4 | Terminated | Psoriasis Treatment Center of Central New Jersey | 5 | 2024-04-09 | 2026-05-20 |
| Pain Outcomes Following Intralesional Corticosteroid Injections Corticosteroid with lidocaine, Corticosteroid with normal saline - Keloid, Alopecia Areata | Phase 4 | Completed | Vanderbilt University Medical Center | 31 | 2018-10-01 | 2021-03-11 |
Acne Vulgaris (1) · Alopecia Areata (1) · Cicatrix, Hypertrophic (1) · Dermoid Cyst (1) · Granuloma Annulare (1) · Keloid (1) · Keratoacanthoma (1) · Lichen Planus (1) · Neurodermatitis (1) · Scleroderma, Localized (1)
Acneiform Eruptions (1) · Alopecia (1) · Cicatrix (1) · Collagen Diseases (1) · Connective Tissue Diseases (1) · Cysts (1) · Dermatitis (1) · Fibrosis (1) · Granuloma (1) · Hair Diseases (1) · Hypotrichosis (1) · Lichenoid Eruptions (1) · Necrobiotic Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Adrenal Cortex Hormones (1) · Lidocaine (1) · Saline Solution (1) · upadacitinib (1)
Psoriasis Treatment Center of Central New Jersey (1) · Vanderbilt University Medical Center (1)
United States (2)
Brian Drolet, MD (1)